Optimization of inhalation treatment – Assessment of the influence of diluent and air humidity on particle distribution of colistin administered by BCTS method [bronchial control treatment system] Source: Annual Congress 2010 - Drug delivery and pharmacokinetics I Year: 2010
Optimization of inhalation treatment – Evaluation of influence of spacer integrated with the spirometer on aerosol particle distribution from pMDI-EB Source: Annual Congress 2010 - Drug delivery and pharmacokinetics I Year: 2010
Comparative in vitro performance of a new re-usable breath-actuated nebulizer (BAN) with other high performance systems intended for domiciliary use – 2: Portable battery-compressor Source: Annual Congress 2012 - The best of pharmacology treatments of airway diseases: new devices and drugs Year: 2012
Characterization of the performance of a new portable jet nebulizer system for the delivery of budesonide suspension for nebulization Source: Annual Congress 2008 - Wheezing in preschool children Year: 2008
Peripheral deposition of α1-protease inhibitor using commercial inhalation devices Source: Eur Respir J 2003; 22: 263-267 Year: 2003
Pharmacokinetics of tobramycin nebulizer solution (300mg/4ml) administered by Pari e-Flow rapid vs Pari LC plus nebulizer in patients with cystic fibrosis and Pseudomonas aeruginosa infection Source: Annual Congress 2012 - Cystic fibrosis (adults and children): new aspects of risk factors, treatments and diagnosis Year: 2012
Comparative in vitro performance of a new re-usable breath-actuated nebulizer (BAN) with other high performance systems intended for domiciliary use – 1: Table-top compressors Source: Annual Congress 2012 - Translational respiratory medicine in asthma and COPD Year: 2012
Effect of 3 different nebulisers on the aerosol delivery performance of isotonic disodium comoglycate (IsoCROM) Source: Eur Respir J 2006; 28: Suppl. 50, 212s Year: 2006
Optimization of inhalation treatment – Evaluation of influence of PNEUMOlogic® and Optimiser® spacers on aerosol particle distribution from pMDI-EB Source: Annual Congress 2011 - Drug delivery and pharmacokinetics I Year: 2011
Combining inhalation by a breath-actuated nebulizer (BAN) with exhalation with oscillating positive expiratory pressure device (OPEP) offers potential for simultaneous therapy Source: Annual Congress 2013 –Cystic fibrosis: basic and applied science Year: 2013
Fluticasone/salmeterol combined in the new Forspiro® inhaler is as effective and safe as Seretide® Accuhaler® in adult and pediatric asthmatics Source: Annual Congress 2011 - Drug delivery and pharmacokinetics I Year: 2011
Chronic inhalation toxicity study of nebulized alpha1 proteinase inhibitor (alpha1 -PI), TAL6005, in rodents Source: Annual Congress 2010 - Models of airways disease Year: 2010
Highly effective delivery of medication is possible in home use with improved breath-actuated nebulizer (BAN) driven by home compressor Source: Annual Congress 2010 - Drug delivery and pharmacokinetics II Year: 2010
Successful conversion of patients using nebulised iloprost from multisonic nebuliser to adaptive aerosol delivery nebuliser Source: Eur Respir J 2007; 30: Suppl. 51, 345s Year: 2007
Efficiency of urgent nebulizer therapy of peakings bronchial allergy at children at a stage [dfoquote]an ambulance station - first aid[dfcquote] Source: Eur Respir J 2001; 18: Suppl. 33, 456s Year: 2001
Pharmacokinetics (PK) and safety of budesonide plus formoterol (BF) (320/9mcg) Spiromax® and BF (400/12mcg) Turbuhaler® following two inhalations (+/– charcoal [char] block) in healthy volunteers (HV) Source: Annual Congress 2013 –LAMA, LABA, ICS and their combinations for the treatment of asthma and COPD Year: 2013
Pharmacokinetics (PK) and safety of budesonide plus formoterol (BF) (160/4.5mcg) Spiromax® and BF (200/6mcg) Turbuhaler® following two inhalations (+/– charcoal [char] block) in healthy volunteers (HV) Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders Year: 2013
In-vitro nebulised dose emission characteristics of a tobramycin solution (75mg/ml) using an I-Neb (I-NEB) and a pari LC+ driven by a TurboBoy compressor (PARI) nebuliser Source: Annual Congress 2011 - Drug delivery and pharmacokinetics I Year: 2011
Lung deposition of two bronchodilators in subjects with (COPD) when administered via standard jet nebulizer or Handihaler® using functional respiratory imaging (FRI). Source: Virtual Congress 2020 – Inhaler devices in COPD: technical advances, adherence studies and more Year: 2020
Reduction of nebulization time can be achieved with a new jet nebulizer design Source: Eur Respir J 2006; 28: Suppl. 50, 211s Year: 2006